Read more https://www.businesswire.com/news/home/20221121005059/en/FogPharma-Announces-178-Million-Series-D-Financing-to-Advance-Pipeline-of-First-in-Class-Helicon-Polypeptide-Therapeutics-Targeting-Major-Cancer-Drivers